Jl. Wemeau et al., WHAT CAN WE EXPECT WITH 1-25-HYDROXYCHOLE CALCIFEROL IN ENDOCRINE ANDMETABOLIC DISEASES, La Revue de medecine interne, 14(6), 1993, pp. 451-451
Serum concentration of 1-25 OHD3 was determined by radioimmunologic as
say in 140 patients with various endocrine or metabolic diseases. It a
ppears that this determination has a poor value for diagnosis and prog
nosis but a real interest for comprehension of bone repercussion in th
ese situations.